Literature DB >> 6179762

Spectral difference index: a single EEG measure of drug effect.

P Irwin.   

Abstract

A single EEG measure of drug effect, the spectral difference index (SDI), was compared to other quantitative measures for its sensitivity to drugs from 7 different clinical classes. The other measures included relative power in 2 c/sec bands from 0 to 17 c/sec, and in 4c/sec bands from 18 to 29 c/sec; relative power and average frequency in the bands 1-5, 6-13 and 14-30 c/sec; and the Hjorth time domain descriptors. The SDI was the most sensitive EEG discriminator between drug and placebo sessions. It is presently used in our pharmaco-EEG studies to test whether a drug has significantly altered the EEG. Its use has been extended to interhemispheric studies.

Mesh:

Substances:

Year:  1982        PMID: 6179762     DOI: 10.1016/0013-4694(82)90184-5

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  6 in total

1.  Effects of granisetron and haloperidol, alone and in combination, on psychometric performance and the EEG.

Authors:  T J Leigh; C G Link; G L Fell
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

2.  The spectral dynamics and its applications in EEG.

Authors:  V Albrecht; M Palus
Journal:  Biol Cybern       Date:  1991       Impact factor: 2.086

3.  Effects of granisetron and lorazepam, alone and in combination, on the EEG of human volunteers.

Authors:  C G Link; T J Leigh; G L Fell
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

4.  EEG and blood level of the potential antidepressant paroxetine after a single oral dose to normal volunteers.

Authors:  G R McClelland; P Raptopoulos
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  The effects of BRL 46470A, a novel 5-HT3 receptor antagonist, and lorazepam on psychometric performance and the EEG.

Authors:  C G Link; T J Leigh; J K Dennison
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

6.  A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers.

Authors:  G R McClelland; S M Cooper; A J Pilgrim
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.